摘要
为破解群众看病难、看病贵难题,近几年国家先后出台药品零加成、集中采购、国谈药品等一系列新政,持续提高医疗保障质量,不断减轻群众医药费用负担。各地在国谈药落地过程中面临着如何加强“医”“保”协同,打通“最后一公里”的困境。南京医保部门立足自身职能,以患者为中心,以保障医保待遇享受为主线,基于“以人为本,保障维度、完善制度、控制流程”的原则,建立保障参保人全要素协同的闭环服务管理体系,破解“进院难”,为国谈药“双通道”全面落地提供实践经验。
Abstract
In order to improve availability and affordability of drugs, China has successively issued a series of new policies including the drug price zero-addition policy, the national volume-based procurement and national medical insurance negotiation drugs, continuously guaranteeing drug qualities and reducing medical burden. However, negotiation drugs fail to cross “the last kilometer” to enter the hospitals because local administration has difficulty in strengthening the coordination of the hospital and the medical insurance institution. Nanjing Healthcare Security Bureau is patient-centered and committed to ensuring the medical insurance benefit according to its own functions. Based on the people-oriented principle, dimensions of assurance, system improvement, process control, a closed-loop service management system with the coordination of all elements of the insured is established to solve the admission problem of negotiation drugs, providing Nanjing scheme for the full implementation of "double channel" of negotiation drugs.
关键词
双通道 /
双重保障 /
南京 /
国谈药品
Key words
double channel /
double assurance /
Nanjing /
negotiation drugs
檀朝明, 黄悦康, 汪茂艳, 刘人榕.
国谈药“双通道”闭环管理的南京实践与探索[J]. 中国医疗保险. 2022, 0(5): 75-78 https://doi.org/10.19546/j.issn.1674-3830.2022.5.015
Practice and Exploration of Negotiation Drugs “ Double Channel” Closed-loop Management in Nanjing[J]. China Health Insurance. 2022, 0(5): 75-78 https://doi.org/10.19546/j.issn.1674-3830.2022.5.015
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 戴伟. 用市场思维引导谈判药品落地[J].中国社会保障,2021(08):27.
[2] 张钰婉,谈在祥,卢亚娟.国家谈判药品“双通道”模式实施现状及优化建议——以S市为例[J].卫生经济研究,2022,39(04):15-18+23.DOI:10.14055/j.cnki.33-1056/f.2022.04.004.
[3] 张博,丁锦希,陈烨,李伟.国家医保谈判药品“双通道”政策动因与实施模式[J].世界临床药物,2021,42(09):709-716.DOI:10.13683/j.wph.2021.09.001.
[4] 刁仁昌,卢旻,陈翀等.国家谈判药品落地南京的实践与思考[J].药学进展,2021,45(10):769-774.
[5] 郑登滋,李玉水,陈纯等.福建省推进国家谈判药品政策落地情况调研及实证分析——基于集中采购与特药药房数据[J].中国医疗保险,2021(10):30-35.DOI:10.19546/j.issn.1674-3830.2021.10.002.
[6] 南京市医疗保障局,南京市卫生健康委员会.关于建立完善国家医保谈判药品“双通道”管理机制的实施方案[N].宁医发〔2021〕70号.